Skip to main content

Table 2 Genes categorized as QLVD and QLCU in both T4 treatments

From: Effect of thyroid hormone concentration on the transcriptional response underlying induced metamorphosis in the Mexican axolotl (Ambystoma)

Gene

Probe-set ID

Fold Change 5 nM

Fold Change 50 nM

Profile

Serpin peptidase inhibitor clade B member 10

SRV_02418_at

3.60

3.24

QLCU

Serpin peptidase inhibitor clade B member 2

SRV_04787_s_at

4.23

3.76

QLCU

N/A

SRV_05867_a_at

21.70

21.44

QLCU

N/A

SRV_05889_x_at

11.05

11.01

QLCU

N/A

SRV_06225_at

24.98

26.20

QLCU

N/A

SRV_07624_x_at

9.64

9.60

QLCU

N/A

SRV_10263_at

72.28

70.70

QLCU

N/A

SRV_10508_a_at

86.94

86.10

QLCU

Keratin 6E

SRV_14426_at

2.97

2.95

QLCU

WAP four-disulfide core domain 5

SRV_05575_at

24.23

23.40

QLCU

Keratin 4

SRV_12057_at

327.01

417.46

QLCU

Desmin

SRV_01373_at

-51.18

-50.21

QLVD

N/A

SRV_01375_at

-6.03

-5.90

QLVD

  1. N/A refers to genes that do not have established orthologies to human. Probe-set ID represents the unique identifier for each probe-set on the custom Ambystoma GeneChip. Fold change 5 nM refers to the maximum fold change observed in the 5 nM T4 treatment relative to Day 0 controls. Fold change 50 nM refers to the maximum fold change observed in the 50 nM T4 treatment relative to Day 0 controls. Profile refers to the expression profile for each gene obtained from regression analyses on the 5 and 50 nM T4 datasets. QLCU refers to the quadratic linear concave up regression profile and QLVD refers to the quadratic linear convex down regression profile.